Remove Access Remove Cannabinoids Remove Collective Remove Extraction
article thumbnail

Featured Brand: Goldsmith Extracts

Kind Meds (Cannabis Education Blog)

We’re proud to feature Goldsmith Extracts, a legendary Arizona cannabis company, renowned for its creation of highly potent, medical-grade cannabis extracts. Why We Love Goldsmith Extracts There are, of course, plenty of cannabis extracts and refined concentrates on the retail cannabis market.

article thumbnail

Lazarus Naturals Launches Its New Sleep Collection Introducing CBN

Cannabis Law Report

New product line features alternative cannabinoids like CBG and CBN, in addition to effective, functional ingredients for healthy sleeping habits. The company recently announced its Sleep Collection , introducing the addition of CBN—known to improve sleep and reduce pain. “It Lazarus Naturals Sleep Collection Product Line.

Sleep 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Radicle Science and Open Book Extracts Announce New Alliance to Advance Consumer Trust and CBD Industry Validation

Cannabis Law Report

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”. About Radicle Science. Radicle Science is a transformative healthtech B-corp offering the first ever path to natural product validation at scale.

article thumbnail

Clever Leaves Holdings Begins Sales of Cannabis Extracts in Germany Through Ethypharm Partnership

Cannabis Law Report

Following a March 2021 supply agreement signed by the two companies providing Ethypharm access to Clever Leaves Holdings EU GMP certified cannabis extracts, the shipment includes two products: a 100 mg CBD with 3 mg THC per gram formulation and a 200 mg CBD with 6 mg THC per gram formulation. About Clever Leaves Holdings Inc.

article thumbnail

Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

Cannabis Law Report

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

article thumbnail

The Tip of the Spear Piercing the Regulated Cannabis Industry: How Intoxicating Hemp Cannabinoids and the Illicit Market Pose Significant Challenges to the Emerging Industry

Cannabis Law Report

Unfortunately, this appetite combined with a lack of access to regulated marijuana has perpetuated both a robust and unregulated illicit marijuana market, and an unregulated hemp industry where intoxicating hemp-derived cannabinoids like Delta-8 THC, Delta-9 THC, THC-O and HHC are freely sold directly to consumers.

article thumbnail

Memo to Congress: Fix the Farm Bill

Project CBD

Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids.